| Q55111427 | Anthropometric and other risk factors for ovarian cancer in a case-control study. |
| Q37356693 | Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy |
| Q44370973 | Cancer incidence in a cohort of infertile women who underwent in vitro fertilization |
| Q35131946 | Cancer risks associated with the diagnosis of infertility |
| Q37551696 | Current understanding of risk factors for ovarian cancer |
| Q64945254 | Do the Fertility Drugs Increase the Risk of Cancer? A Review Study. |
| Q37703912 | Does ovulation induction increase the risk of gynecological cancer? |
| Q43271918 | Effects of ovulation induction agents on ovarian surface epithelium in rats |
| Q33936537 | Epidemiological and genetic factors associated with ovarian cancer |
| Q33812564 | Epithelial ovarian cancer, infertility and induction of ovulation: possible pathogenesis and updated concepts |
| Q93501192 | Female infertility |
| Q36901734 | Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study |
| Q53517309 | Fertility drugs and ovarian cancer: what are the practical implications of the ongoing debate? |
| Q71952585 | Fertility drugs and ovarian epithelial cancer: is there a link? |
| Q33931378 | Fertility drugs and the risk of breast and gynecologic cancers |
| Q33608317 | Fertility drugs, reproductive strategies and ovarian cancer risk. |
| Q33541940 | Hormonal interactions in ovarian cancer |
| Q38427798 | In vitro fertilization is associated with an increased risk of borderline ovarian tumours |
| Q37639055 | In vivo evaluation of the genotoxic effects of gonadotropins on rat reticulocytes |
| Q33700696 | Induction of ovulation and borderline ovarian cancer--the hormonal connection? |
| Q74245185 | Infertility treatment after conservative management of borderline ovarian tumors |
| Q58176131 | Infertility, fertility drugs, and invasive ovarian cancer: a case-control study |
| Q33648309 | In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services |
| Q35838031 | Is There a Relationship between Ovarian Epithelial Dysplasia and Infertility? |
| Q28362313 | Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from human cumulus cells |
| Q36269682 | Leukemia inhibitory factor decreases the arylamine N-acetyltransferase activity in human cumulus granulosa cells |
| Q36876544 | Long-term effects of ovulation-stimulating drugs on cancer risk |
| Q33658382 | Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature |
| Q50929056 | Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. |
| Q37222479 | Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment |
| Q31147531 | Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls |
| Q64079499 | Ovarian cancer in the world: epidemiology and risk factors |
| Q73251993 | Ovarian hyperstimulation and oophorectomy following accidental daily clomiphene citrate use over three consecutive months |
| Q58175993 | Ovarian stimulation and borderline ovarian tumors: a case-control study |
| Q43715513 | Ovulation induction and risk of endometrial cancer: a pilot study |
| Q34369162 | Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort |
| Q37225731 | Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. |
| Q54117850 | Potential tumor suppressing role of microRNA-545 in epithelial ovarian cancer. |
| Q28183254 | Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells |
| Q34623393 | Protecting female fertility from cancer therapy. |
| Q35540547 | Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort |
| Q34505781 | Risk of cancer after use of fertility drugs with in-vitro fertilisation |
| Q24200437 | Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility |
| Q24241692 | Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility |
| Q53373961 | Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage‐dependent and ‐independent growth in human ovarian surface epithelial cell lines |
| Q42628025 | Shared oocyte donation: society's benefits |
| Q51102355 | The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk. |
| Q52899967 | The incidence of borderline ovarian tumors in Israel: a population-based study. |
| Q47668677 | The risk for cancer among children of women who underwent in vitro fertilization |
| Q34443562 | Use of fertility drugs and risk of ovarian cancer |
| Q34015977 | Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study |
| Q36153070 | Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study |